These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28938963)

  • 1. Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome.
    Kaushal S; Wehman B; Pietris N; Naughton C; Bentzen SM; Bigham G; Mishra R; Sharma S; Vricella L; Everett AD; Deatrick KB; Huang S; Mehta H; Ravekes WA; Hibino N; Difede DL; Khan A; Hare JM
    Am Heart J; 2017 Oct; 192():48-56. PubMed ID: 28938963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.
    Ishigami S; Ohtsuki S; Tarui S; Ousaka D; Eitoku T; Kondo M; Okuyama M; Kobayashi J; Baba K; Arai S; Kawabata T; Yoshizumi K; Tateishi A; Kuroko Y; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
    Circ Res; 2015 Feb; 116(4):653-64. PubMed ID: 25403163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
    Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
    Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections.
    Burkhart HM; Qureshi MY; Rossano JW; Cantero Peral S; O'Leary PW; Hathcock M; Kremers W; Nelson TJ;
    J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1614-1623. PubMed ID: 31345560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
    Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
    JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
    Greene SJ; Epstein SE; Kim RJ; Quyyumi AA; Cole RT; Anderson AS; Wilcox JE; Skopicki HA; Sikora S; Verkh L; Tankovich NI; Gheorghiade M; Butler J
    J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):283-290. PubMed ID: 26479144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial.
    Tarui S; Ishigami S; Ousaka D; Kasahara S; Ohtsuki S; Sano S; Oh H
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1198-1207, 1208.e1-2. PubMed ID: 26232942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells improve cardiac function and left ventricular remodeling in a heart transplantation model.
    Montanari S; Dayan V; Yannarelli G; Billia F; Viswanathan S; Connelly KA; Keating A
    J Heart Lung Transplant; 2015 Nov; 34(11):1481-8. PubMed ID: 26234284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous Cardiac Stem Cell Injection in Patients with Hypoplastic Left Heart Syndrome (CHILD Study).
    Kaushal S; Hare JM; Shah AM; Pietris NP; Bettencourt JL; Piller LB; Khan A; Snyder A; Boyd RM; Abdullah M; Mishra R; Sharma S; Slesnick TC; Si MS; Chai PJ; Davis BR; Lai D; Davis ME; Mahle WT
    Pediatr Cardiol; 2022 Oct; 43(7):1481-1493. PubMed ID: 35394149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.
    Trachtenberg B; Velazquez DL; Williams AR; McNiece I; Fishman J; Nguyen K; Rouy D; Altman P; Schwarz R; Mendizabal A; Oskouei B; Byrnes J; Soto V; Tracy M; Zambrano JP; Heldman AW; Hare JM
    Am Heart J; 2011 Mar; 161(3):487-93. PubMed ID: 21392602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial.
    Kaushal S; Hare JM; Hoffman JR; Boyd RM; Ramdas KN; Pietris N; Kutty S; Tweddell JS; Husain SA; Menon SC; Lambert LM; Danford DA; Kligerman SJ; Hibino N; Korutla L; Vallabhajosyula P; Campbell MJ; Khan A; Naioti E; Yousefi K; Mehranfard D; McClain-Moss L; Oliva AA; Davis ME
    Eur Heart J Open; 2023 Mar; 3(2):oead002. PubMed ID: 36950450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.
    Guijarro D; Lebrin M; Lairez O; Bourin P; Piriou N; Pozzo J; Lande G; Berry M; Le Tourneau T; Cussac D; Sensebe L; Gross F; Lamirault G; Huynh A; Manrique A; Ruidavet JB; Elbaz M; Trochu JN; Parini A; Kramer S; Galinier M; Lemarchand P; Roncalli J
    Int J Cardiol; 2016 Apr; 209():258-65. PubMed ID: 26901787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.
    Butler J; Epstein SE; Greene SJ; Quyyumi AA; Sikora S; Kim RJ; Anderson AS; Wilcox JE; Tankovich NI; Lipinski MJ; Ko YA; Margulies KB; Cole RT; Skopicki HA; Gheorghiade M
    Circ Res; 2017 Jan; 120(2):332-340. PubMed ID: 27856497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study.
    Elabd C; Centeno CJ; Schultz JR; Lutz G; Ichim T; Silva FJ
    J Transl Med; 2016 Sep; 14(1):253. PubMed ID: 27585696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial.
    Noriega DC; Ardura F; Hernández-Ramajo R; Martín-Ferrero MÁ; Sánchez-Lite I; Toribio B; Alberca M; García V; Moraleda JM; Sánchez A; García-Sancho J
    Transplantation; 2017 Aug; 101(8):1945-1951. PubMed ID: 27661661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.
    Reinders ME; Dreyer GJ; Bank JR; Roelofs H; Heidt S; Roelen DL; Zandvliet ML; Huurman VA; Fibbe WE; van Kooten C; Claas FH; Rabelink TJ; de Fijter JW
    J Transl Med; 2015 Nov; 13():344. PubMed ID: 26537851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of tricuspid regurgitation in patients with hypoplastic left heart syndrome undergoing tricuspid valvuloplasty.
    Bautista-Hernandez V; Brown DW; Loyola H; Myers PO; Borisuk M; del Nido PJ; Baird CW
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):832-8; discussion 838-40. PubMed ID: 25129586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired power output and cardiac index with hypoplastic left heart syndrome: a magnetic resonance imaging study.
    Sundareswaran KS; Kanter KR; Kitajima HD; Krishnankutty R; Sabatier JF; Parks WJ; Sharma S; Yoganathan AP; Fogel M
    Ann Thorac Surg; 2006 Oct; 82(4):1267-75; discussion 1275-7. PubMed ID: 16996919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.
    Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
    J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoplastic left heart syndrome.
    Connor JA; Thiagarajan R
    Orphanet J Rare Dis; 2007 May; 2():23. PubMed ID: 17498282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.